NIP
OMIC

Nicholas Investment Partners’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Nicholas Investment Partners’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,330
Closed -$3.28M – 212
2022
Q1 		$3.28M Sell
17,330
-6,704
-28% -$1.55M 0.23% 120
2021
Q4 		$8.34M Buy
24,034
+2,374
+11% +$920K 0.53% 73
2021
Q3 		$7.27M Buy
21,660
+669
+3% +$343K 0.53% 73
2021
Q2 		$17.3M Buy
+20,991
New +$16.3M 1.09% 32

Other funds holding OMIC

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $110M AUM
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Nicholas Investment Partners's OMIC Position: Q2 2022 in Review

Nicholas Investment Partners sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2022, closing a stake of 17,330 shares — an estimated $3.28M sold.

Nicholas Investment Partners first reported a position in OMIC in Q2 2021 and held it in 4 quarters. The position peaked at $17.3M in Q2 2021. 76 funds tracked by Wall St. Rank hold OMIC as of Q2 2022.

  • Nicholas Investment Partners reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 17,330 Singular Genomics Systems, Inc. Common Stock shares in Q2 2022, an estimated $3.28M.
  • Nicholas Investment Partners first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Nicholas Investment Partners's Singular Genomics Systems, Inc. Common Stock position peaked at $17.3M in Q2 2021.
  • 76 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2022.

Based on Nicholas Investment Partners's 13F filing for Q2 2022, filed 10 Aug 2022.